Laurent Fischer
Director; Chair Science and Technology Committee; Member Compensation Committee at atai Life Sciences
About
Laurent Fischer is CEO and President of Adverum Biotechnologies and sits on the boards of Mirum Pharmaceuticals, Lycia Therapeutics, and Teal. He previously chaired CTI Biopharma, led Tobira Therapeutics as CEO (later acquired by Allergan), and held leadership positions at Jennerex, RXCentric, MedVantx, Dupont Pharmaceuticals, Dupont-Merck, and F. Hoffmann-La Roche. He holds an undergraduate degree from the University of Geneva and a medical degree from the Geneva Medical School in Switzerland.
Invests in
Biotech
Investments
Board seats
Lycia TherapeuticsMirum Pharmaceuticals, Inc.Teal
As listed on the firm's website.
Colleagues at atai Life Sciences
Amir Kalali
Director at atai Life Sciences
Andrea Heslin Smiley
Director at atai Life Sciences
Anne Johnson
Chief Accounting Officer at atai Life Sciences
Christian Angermayer
Founder and Chairman of the Board at atai Life Sciences
Gerd Kochendoerfer
Chief Operating Officer at atai Life Sciences
Glenn Short
Chief Scientific Officer at atai Life Sciences
John Hoffman
Director at atai Life Sciences
Kevin Craig
Chief Medical Officer at atai Life Sciences